We are live on
!
Find out more
MIM
Martin Investment Management Portfolio holdings
AUM
$300M
1-Year Est. Return
6.05%
This Fund
S&P 500
This Quarter
Est. Return
-0.03%
1 Year Est. Return
+6.05%
3 Year Est. Return
+44.71%
5 Year Est. Return
+50.94%
10 Year Est. Return
+276.43%
AUM
$599M
AUM Growth
-$41.5M
(-6.5%)
Cap. Flow
-$38.4M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
38.81%
Holding
42
New
2
Increased
11
Reduced
27
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$14.6M |
| 2 |
Check Point Software Technologies
CHKP
|
+$4.8M |
| 3 |
Medtronic
MDT
|
+$2.93M |
| 4 |
NXP Semiconductors
NXPI
|
+$2.77M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$2.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$13.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$3.79M |
| 3 |
Abbott
ABT
|
+$3.72M |
| 4 |
Stryker
SYK
|
+$3.3M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$3.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Technology | 21.97% |
| 3 | Financials | 19.64% |
| 4 | Industrials | 8.99% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$477B
| $26.9M | 4.49% |
305,317
-32,365
| -10% | -$3.09M |
|
2
MSCI
MSCI
$40B
| $26.1M | 4.35% |
338,275
-36,346
| -10% | -$2.75M |
|
3
Apple
AAPL
$4.89T
| $25.6M | 4.27% |
1,070,184
-99,044
| -8% | -$2.46M |
|
|
FISV
4
Fiserv Inc
FISV
$27.2B
| $24.5M | 4.09% |
451,248
-62,086
| -12% | -$3.2M |
|
|
5
Stryker
SYK
$127B
| $22.6M | 3.77% |
188,353
-29,546
| -14% | -$3.3M |
|
6
Accenture
ACN
$89.9B
| $21.8M | 3.64% |
192,687
-1,189
| -0.6% | -$138K |
|
7
Berkshire Hathaway Class B
BRK.B
$1.07T
| $21.7M | 3.63% |
150,065
-14,240
| -9% | -$2.04M |
|
8
Booking.com
BKNG
$138B
| $21.3M | 3.55% |
426,275
-46,225
| -10% | -$2.4M |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $21.3M | 3.55% |
215,491
-26,050
| -11% | -$2.69M |
|
|
10
Thermo Fisher Scientific
TMO
$211B
| $20.8M | 3.48% |
141,040
-25,667
| -15% | -$3.79M |
|
11
Omnicom Group
OMC
$22.7B
| $20.2M | 3.37% |
247,787
-20,905
| -8% | -$1.74M |
|
12
Colgate-Palmolive
CL
$72.6B
| $20M | 3.34% |
273,356
-25,018
| -8% | -$1.78M |
|
13
ExxonMobil
XOM
$651B
| $19.8M | 3.3% |
210,771
-19,618
| -9% | -$1.73M |
|
14
Verisk Analytics
VRSK
$26.4B
| $19.8M | 3.3% |
243,616
-21,476
| -8% | -$1.68M |
|
15
Procter & Gamble
PG
$343B
| $19.7M | 3.29% |
233,160
-21,110
| -8% | -$1.73M |
|
16
Johnson & Johnson
JNJ
$635B
| $19.7M | 3.29% |
162,420
-23,747
| -13% | -$2.7M |
|
17
Gilead Sciences
GILD
$161B
| $19.5M | 3.26% |
234,218
-31,413
| -12% | -$2.79M |
|
18
3M
MMM
$89B
| $18.9M | 3.15% |
129,004
-6,593
| -5% | -$930K |
|
19
Travelers Companies
TRV
$80.8B
| $18.7M | 3.12% |
157,034
-4,368
| -3% | -$494K |
|
20
VF Corp
VFC
$6.68B
| $16.1M | 2.68% |
277,911
+4,109
| +2% | +$243K |
|
21
Alphabet (Google) Class A
GOOGL
$3.91T
| $16M | 2.66% |
453,880
-65,620
| -13% | -$2.41M |
|
22
Oracle
ORCL
$331B
| $15.8M | 2.63% |
385,797
-73,200
| -16% | -$2.92M |
|
23
RTX Corp
RTX
$287B
| $15.2M | 2.54% |
235,876
-13,392
| -5% | -$857K |
|
|
24
CVS Health
CVS
$137B
| $14M | 2.34% |
+146,601
| New | +$14.6M |
|
25
American Express
AXP
$223B
| $13.6M | 2.27% |
223,774
-13,589
| -6% | -$861K |
|
Similar funds
RL
JGIA
RCA
PIAS
KEM
I
AFS
GB
Martin Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, Martin Investment Management held 42 positions worth $599M, down 6.5% from $641M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Martin Investment Management withdrew a net $38.4M in Q2 2016, closing 2 positions and reducing 27 holdings. Its most notable exit was Cencora, an estimated $13.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
Against the trend, Martin Investment Management opened a new position in CVS Health worth $14M.
- Martin Investment Management's largest Q2 2016 buy was CVS Health: 146,601 shares worth $14M.
- Martin Investment Management added most to Medtronic in Q2 2016, an estimated $2.93M increase.
- Martin Investment Management's biggest Q2 2016 reduction was Thermo Fisher Scientific, cutting an estimated $3.79M.
- Martin Investment Management fully exited Cencora in Q2 2016, selling an estimated $13.9M.
- Martin Investment Management's ten largest holdings make up 39% of its $599M portfolio in Q2 2016.
- Martin Investment Management opened 2 new positions and closed 2 in Q2 2016.
- Martin Investment Management's portfolio value fell 6.5% quarter-over-quarter to $599M.
Based on Martin Investment Management's 13F filing for Q2 2016, filed 21 Jul 2016.